Farinea, G.; Calabrese, M.; Carfì, F.; Saporita, I.; Poletto, S.; Delcuratolo, M.D.; Turco, F.; Audisio, M.; Di Stefano, F.R.; Tucci, M.;
et al. Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis. Cells 2024, 13, 1396.
https://doi.org/10.3390/cells13161396
AMA Style
Farinea G, Calabrese M, Carfì F, Saporita I, Poletto S, Delcuratolo MD, Turco F, Audisio M, Di Stefano FR, Tucci M,
et al. Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis. Cells. 2024; 13(16):1396.
https://doi.org/10.3390/cells13161396
Chicago/Turabian Style
Farinea, Giovanni, Mariangela Calabrese, Federica Carfì, Isabella Saporita, Stefano Poletto, Marco Donatello Delcuratolo, Fabio Turco, Marco Audisio, Francesco Rosario Di Stefano, Marcello Tucci,
and et al. 2024. "Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis" Cells 13, no. 16: 1396.
https://doi.org/10.3390/cells13161396
APA Style
Farinea, G., Calabrese, M., Carfì, F., Saporita, I., Poletto, S., Delcuratolo, M. D., Turco, F., Audisio, M., Di Stefano, F. R., Tucci, M., & Buttigliero, C.
(2024). Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis. Cells, 13(16), 1396.
https://doi.org/10.3390/cells13161396
